Atlas Trials

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

Clinical trial NCT00450814 · COMPLETED

Trial details

NCT number
NCT00450814
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Start date
2006-11-30
Primary completion
2018-07-10
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.